Quizartinib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12874 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 9 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acute myeloid leukemia and myelodysplastic syndromes related to radiation | KG + DL |
| 2 | acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent | KG + DL |
| 3 | 5q35 microduplication syndrome | KG + DL |
| 4 | bulbar polio | KG + DL |
| 5 | neuralgic amyotrophy | KG + DL |
| 6 | amyotrophic neuralgia | KG + DL |
| 7 | acute panmyelosis with myelofibrosis | KG + DL |
| 8 | myelodysplastic/myeloproliferative disease | KG + DL |
| 9 | bilineal acute myeloid leukemia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.